The silent invaders: Biofilms in neurological, cardiovascular, and metabolic diseases.

Vinay Kumar,Anuradha Tyagi

Published 2025 in Life Science

ABSTRACT

Biofilms, intricate microbial communities enclosed in a protective extracellular matrix, are conventionally linked to localized illnesses. Emerging data indicates that biofilms significantly contribute to systemic disorders beyond traditional infections. Bacterial biofilms may induce neuroinflammation and impair the blood-brain barrier in neurodegenerative illnesses including Alzheimer's and Parkinson's. In cardiovascular illnesses, biofilms from oral and gut microbes play a role in atherosclerosis, endocarditis, and hypertension. In metabolic illnesses, biofilms affect insulin resistance and metabolic endotoxemia, worsening conditions such as obesity and type 2 diabetes. Moreover, biofilms are associated with cancer progression, especially in colorectal and gastric malignancies, as they provide a tumor-promoting milieu via chronic inflammation and the generation of bacterial metabolites. Biofilms advance disease development by increasing chronic inflammation, evading immunological responses, and allowing microbial translocation, aspects that have been previously underestimated. Identifying biofilms as significant contributors to systemic disease presents novel avenues for innovative therapies and enhanced patient outcomes across various chronic illnesses. Thus, this review examines the increasing influence of biofilms on chronic inflammatory diseases, neurological disorders, cardiovascular diseases, metabolic syndromes, and cancer.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 175 references · Page 1 of 2

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1